Obesity Protects Cancer from Drugs Targeting Blood Vessels

Yihai Cao1

  • 1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Cell Metabolism
|June 7, 2018
PubMed

Insights

Obesity promotes resistance to anti-angiogenic cancer drugs like anti-VEGF therapies. Understanding this link in breast cancer offers new strategies to improve treatment effectiveness for obese patients.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolic Syndrome

Background:

  • Anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF) are standard cancer treatments.
  • Clinical efficacy of these drugs is often limited by the development of resistance.
  • The influence of patient metabolic status on drug response is an emerging area of research.

Purpose of the Study:

  • To investigate the mechanistic role of obesity in the development of resistance to anti-VEGF therapy.
  • To explore potential therapeutic strategies to overcome obesity-induced drug resistance in breast cancer.

Main Methods:

  • Utilized human patient data and preclinical murine models of breast cancer.
  • Analyzed molecular and cellular mechanisms linking obesity to anti-VEGF drug response.
  • Assessed the impact of obesity on tumor angiogenesis and drug efficacy.

Main Results:

  • Obesity was identified as a significant factor contributing to acquired resistance to anti-VEGF therapy.
  • Specific metabolic pathways associated with obesity were found to drive pro-angiogenic signaling, counteracting drug effects.
  • Obese models exhibited reduced sensitivity to anti-VEGF agents compared to non-obese counterparts.

Conclusions:

  • Obesity impairs the effectiveness of anti-VEGF cancer drugs by promoting therapeutic resistance.
  • Targeting obesity-related metabolic alterations may represent a viable strategy to enhance anti-angiogenic therapy outcomes.

Related Concept Videos

Structure of Blood Vessels01:15

Structure of Blood Vessels

Blood is circulated throughout the human body through a network of blood vessels called the circulatory system. This system includes arteries that transport blood from the heart to various body parts. These arterial pathways divide into smaller vessels until they reach the arterioles, which further split into capillaries. It is within these minuscule capillaries that the exchange of nutrients and waste products takes place. After this exchange, the blood is collected by venules, which fuse to...
9.7K
Anatomy of Blood Vessels01:20

Anatomy of Blood Vessels

The vascular system, an integral part of the circulatory system, comprises various blood vessels that play crucial roles in maintaining the body's homeostasis. These blood vessels form a complex and efficient circulatory network. The three primary categories of blood vessels are the arteries, veins, and capillaries.
Arteries
Arteries circulate oxygenated blood from the heart, except the pulmonary artery, which transports deoxygenated blood to the lungs. Large arteries, such as the aorta,...
2.8K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.5K
Overview of Blood Vessels01:14

Overview of Blood Vessels

The human cardiovascular system comprises five primary types of blood vessels: arteries, arterioles, veins, venules, and capillaries, each serving unique functions.
Arteries and Arterioles: Arteries are muscular and elastic vessels that primarily carry oxygenated blood from the heart to body tissues, except for the pulmonary artery, which carries deoxygenated blood. They have thick walls to withstand high pressure and contain a layer of muscle tissue, allowing them to expand or contract as...
11.0K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
287